COMPARISON OF HEMODYNAMIC STATUS AND COMPLICATIONS BETWEEN TWO DIFFERENT DOSES OF INTRAMYOMETRIAL VASOPRESSIN DURING LAPAROSCOPIC MYOMECTOMY: A RETROSPECTIVE STUDY, THE LESSER THE BETTER

NUPUR MODA; SUSHREE DAS; MADHUSMITA PATRO; PRERNA BISWAL

doi:10.22159/ajpcr.2021.v14i10.42927

Authors

NUPUR MODA Department of Anesthesiology and Pain Medicine, Institute of Medical Sciences and SUM Hospital, Bhubaneswar, Odisha, India.
SUSHREE DAS Department of Anesthesiology and Pain Medicine, Institute of Medical Sciences and SUM Hospital, Bhubaneswar, Odisha, India.
MADHUSMITA PATRO Department of Anesthesiology and Pain Medicine, Institute of Medical Sciences and SUM Hospital, Bhubaneswar, Odisha, India.
PRERNA BISWAL Department of Anesthesiology and Pain Medicine, Institute of Medical Sciences and SUM Hospital, Bhubaneswar, Odisha, India.

DOI:

https://doi.org/10.22159/ajpcr.2021.v14i10.42927

Keywords:

Intramyometrial vasopressin, Myomectomy, Bradycardia, Pulmonary edema, Hypotension

Abstract

Objective: Our aim is comparison of hemodynamic status and complications between two different doses of intramyometrial vasopressin during laparoscopic myomectomy.

Methods: We did a retrospective analysis of hemodynamic status and its anesthetic concerns in patients who received two different doses of intramyometrial vasopressin. Eighty patients undergoing laparoscopic myomectomy under general anesthesia were divided into two groups of 40 patients in each group. In Group A (n=40), 10 units of intramyometrial vasopressin in 200 ml of normal saline were given and, in Group B, 20 units of intramyometrial vasopressin in 200 ml of NS were given intraoperatively by surgeon.

Results: 20 units intramyometrial vasopressin used dogmatically by surgeons drops blood loss but it is connected with cardiovascular impediments. Hence, 10 units of intramyometrial vasopressin as compared to 20 units which are used by some surgeons are associated with similar blood loss and lesser side effects such as bradycardia, pulmonary edema, hypotension, blood loss, and increased airway pressure.

Conclusion: Hence, anesthesiologists and gynecologists must take the precautions to escape and minimize the frequency of impediments with intramyometrial vasopressin by selecting the appropriate dosage of vasopressin.

Downloads

Download data is not yet available.

References

Cramer SF, Patel A. The frequency of uterine leiomyomas. Am J Clin Pathol 1990; 94:435-8.

Zeqja E, Qirko R. Vasopressine in laparoscopic myomectomy, a review over the effectiveness, dosage and possible complications. IOSR J Pharm 2016; 6:23-7.

Wing DA, Goharkhay N, Felix JC, Rostamkhani M, Naidu YM, Kovacs BW. Expression of the oxytocin and V1a vasopressin receptors in human myometrium in differing physiologic states and following misoprostol administration. Gynecol Obstet Invest 2006; 62:181-5.

Shimanuki H, Takeuchi H, Kitade M, Kikuchi I, Kumakiri J, Kinoshita K. The effect of vasopressin on local and general circulation during laparoscopic surgery. J Minim Invasive Gynecol 2006; 13:190- 4.

Takeuchi H, Shimanuki H, Kobori H, Kitade M, Kikuchi I, Kinoshita K. Effect of vasopressin on blood flow and RI of the uterine artery during laparoscopic myomectomy. J Minim Invasive Gynecol 2005; 12:10-1.

Nezhat F, Admon D, Nezhat CH, Dicorpo JE, Nezhat C. Life-threatening hypotension after vasopressin injection during operative laparoscopy, followed by uneventful repeat laparoscopy. J Am Assocc Gynecol Laparosc 1994; 2:83-6.

Hobo R, Netsu S, Koyasu Y, Tsutsumi O. Bradycardia and cardiac arrest caused by intramyometrial injection of vasopressin during a laparoscopically assisted myomectomy. Obstet Gynecol 2009; 113:484- 6.

Kimura T, Kucui C. Effectiveness of hormonal tourniquet by vasopressin during myomectomy through vasopressin V1a receptor ubiquitously expressed in myometrium. Gynecol Obstet Invest 2002; 54:125-31.

Park KS, Yoo KY. Role of vasopressin in current anesthetic practice. Korean J Anesthesiol 2017; 70:245-57.

Tsuda A, Kanaoka Y. Submyometrial vasopressin injection before microwave ablation of vascular-rich submucosalmyomas: A preliminary case study. Int J Hyperthermia 2019; 36:739-43.

Kakkar B. Is Irrational use of intramyometrial vasopressin justified in anesthesia practice? Anaesth Commun 2017; 1:e102.

Malla UJ, Rong ZS. Role of vasopressin in myomectomy. IJSIT 2018; 7:183-7.

Dillon TF, Marbury BE, Bonsnes RW, Douglas RG, DuVigneaud V. Vasopressin as a hemostatic in gynecologic surgery; a preliminary report. Obstet Gynecol 1958; 11:363-71.

Fletcher H, Frederick J, Hardie M, Simeon D. A randomized comparison of vasopressin and tourniquet as hemostatic agents during myomectomy. Obstet Gynecol 1996; 87:1014-8.

Jayaraman L, Sinha A, Punhani D. Intramyometrial vasopressin: Anesthesiologists’ nightmare. J Anaesthesiol Clin Pharmacol 2013; 29:135-6.

Riess ML, Ulrichs JG, Pagel PS, Woehlck HJ. Case report: Severe vasospasm mimics hypotension after high-dose intrauterine vasopressin. Anesth Analg 2011; 113:1103-5.

Barett KE, Boitano S, Barman SM, Brooks HL. Ganong’s Review of Medical Physiology. 24th ed. New York: McGraw-Hill; 2012.

American Heart Association. Guidelines for cardiopulmonary resuscitation and emergency cardiovascular care: Part 7.3: Management of symptomatic bradycardia and tachycardia. Circulation 2005; 112:67- 77.

Frishman G. Vasopressin: If some is good, is more better? Obstet Gynecol 2009; 113:476-7.